Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2017-04-07
Original SEC Filing: Click here

---

Webplus: CO/20170407/6-K/2_EX-99.1/000.htm SEC Original: a17-11044_1ex99d1.htm
China Cord Blood Corporation Receives Notification of HONG KONG, China, April 6, 2017 – China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced The aggregate principal amount of the Notes held by GMSC amounts to US$115 million. The conversion

---

---

Webplus: CO/20170407/6-K/1/000.htm SEC Original: a17-11044_16k.htm
FORM 6-K 7 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x o o o Yes o x Other Events On April 6, 2017, China Cord Blood Corporation (the “Company”) issued a press release announcing the receipt of notices of conversion of all 7% senior convertible notes held

---

Company Info:

Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2017-04-07CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000